Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2009
11/09/2009CA2631071A1 Inhibition of calpain reduces allergic inflammation
11/05/2009WO2009135180A2 A method for generating reference controls for pharmacogenomic testing
11/05/2009WO2009134883A1 Substances and compositions for enhancing dna repair and methods of use
11/05/2009WO2009134714A2 Fusion molecules of rationally-designed dna-binding proteins and effector domains
11/05/2009WO2009134710A2 Methods for enhancing utrophin production via inhibition of microrna
11/05/2009WO2009134681A2 Aav7 viral vectors for targeted delivery of rpe cells
11/05/2009WO2009134487A2 Optimized methods for delivery of dsrna targeting the pcsk9 gene
11/05/2009WO2009134418A2 Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby
11/05/2009WO2009133968A1 Charge conversional ternary polyplex
11/05/2009WO2009133940A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009WO2009133939A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009WO2009133247A1 Neurotrophic factor manf and uses thereof
11/05/2009WO2009132457A1 Fgf-9 and its use relating to blood vessels
11/05/2009WO2009114487A3 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide
11/05/2009WO2009105673A3 Tumor therapy with replication competent sindbis viral vectors
11/05/2009WO2009104896A3 Nucleic-acid pharmaceutical composition for cancer therapy
11/05/2009WO2009102782A3 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates
11/05/2009WO2009070244A3 Methods for inhibiting fascin
11/05/2009WO2009054996A8 Systems and methods for viral therapy
11/05/2009WO2008154333A3 Mir-34 regulated genes and pathways as targets for therapeutic intervention
11/05/2009WO2008124166A8 Fusion proteins of collagen-binding domain and parathyroid hormone
11/05/2009WO2008097503A8 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
11/05/2009WO2008011431A8 Rna interference mediated inhibition of proprotein convertase subtilisin kexin 9 (pcsk9) gene expression using short interfering nucleic acid (sina)
11/05/2009WO2007147168A8 Attenuation of hyperoxia-induced cell death with mitochondrial aldehyde dehydrogenase
11/05/2009US20090275729 Microrna and methods for inhibiting same
11/05/2009US20090275645 Method to induce neovascular formation and tissue regeneration
11/05/2009US20090275642 Dna composition for eliciting an immune response against tumor-associated macrophages
11/05/2009US20090275633 Novel Tumour Suppressor
11/05/2009US20090275133 Antisense modulation of c-reactive protein expression
11/05/2009US20090275100 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/05/2009US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009US20090274708 Recombinant Toxin Fragments
11/05/2009US20090274671 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/05/2009US20090274670 Dph2 gene deletion mutant and uses thereof
11/05/2009US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009CA2725128A1 Neurotrophic factor manf and uses thereof
11/05/2009CA2723276A1 Fgf-9 and its use relating to blood vessels
11/05/2009CA2723169A1 Substances and compositions for enhancing dna repair and methods of use
11/05/2009CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/04/2009EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009EP2113567A1 MicroRNA target site blocking oligos and uses thereof
11/04/2009EP2113566A1 Genes from 20q13 amplicon and their uses
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2113247A2 High efficiency encapsulation of nucleic acids in lipid vesicles
11/04/2009EP2112931A1 Methods and compositions for transermal delivery of nucleotides
11/04/2009EP1620131B1 Ghrh for use in treating chronic renal failure
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/03/2009US7612192 Neisseria genomic sequences and methods of their use
11/03/2009US7612164 Cardiac muscle function and manipulation
11/03/2009US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009US7611884 Toxoplasma gondii nucleic acid molecules
11/03/2009US7611868 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system
11/03/2009US7611833 Comprising an altered MAB1, MAB2, MAB3, or OLE1 gene; evaluating a substance as a positive strand RNA antiviral agent
11/03/2009US7611723 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
11/03/2009CA2418442C Novel helper functions for recombinant vector production
11/03/2009CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009CA2289611C Method for the production of non-group c adenoviral vectors
11/03/2009CA2205379C Yeast-based delivery vehicles
11/03/2009CA2187626C Aav-mediated delivery of dna to cells of the nervous system
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/29/2009WO2009132351A2 Anti-sense microrna expression vectors
10/29/2009WO2009131216A1 Lipid membrane structure modified with oligo(alkylene glycol)
10/29/2009WO2009131166A1 Wnt signaling inhibitor comprising insulin-like growth factor-binding protein
10/29/2009WO2009130208A1 Liver-specific nucleic acid regulatory elements and methods and use thereof
10/29/2009WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009WO2009102465A3 Continuous cell programming devices
10/29/2009WO2009100284A3 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects
10/29/2009WO2009100159A3 Methods of diagnosing and treating parp-mediated diseases
10/29/2009WO2009099991A3 Treatment of cancer
10/29/2009WO2009097119A3 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
10/29/2009WO2002048386A3 Protein-protein interactions
10/29/2009US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
10/29/2009US20090270484 WWOX Vectors and Uses in Treatment of Cancer
10/29/2009US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269368 Pseudomonas exotoxin a-like chimeric immunogens
10/29/2009US20090269361 Constructs for delivery of therapeutic agents to neuronal cells
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269337 Compositions and methods for treating diabetes
10/29/2009CA2722238A1 Liver-specific nucleic acid regulatory elements and methods and use thereof
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/28/2009EP2112229A2 Methods for identifying risk of breast cancer and treatments thereof
10/28/2009EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens
10/28/2009EP1527340B1 Method for identifying substances
10/28/2009EP1497438B1 Means and methods for the production of adenovirus vectors
10/28/2009EP1436003B1 Taci-immunoglobulin fusion proteins
10/28/2009EP1421539B1 Stabilized factor viii with engineered disulfide bonds
10/28/2009EP1371377B1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
10/28/2009EP1346218B1 Tripeptide of fc gamma riia
10/28/2009EP1071758B1 Porcine adenovirus vector
10/28/2009EP1012232B1 Genetically modified tumor-targeted bacteria with reduced virulence
10/28/2009EP0915706B1 Screening methods for compounds useful in the regulation of body weight
10/28/2009CN101565718A Construction method of three-target mosaic type oncolytic adenovirus Ad5/F11 carrier and use thereof
10/28/2009CN101565692A Construction and application of multiple target-point anti-cancer adenoviruses
10/28/2009CN101565459A Streptococcus pneumoniae proteins and nucleic acid molecules
10/28/2009CN101565455A CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
10/28/2009CN100554430C Recombinant plasmids containing B cell activation factor gene promoters with different lengths and their preparation method and application
10/28/2009CN100554428C Nucleic acid sequence for potentiating the expression of useful gene and method therefor
10/28/2009CN100554425C Deletion mutant of a set of hepatitis B HBx gene and application thereof
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 870